|
Valoración DCF de Penumbra, Inc. (PEN) |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Penumbra, Inc. (PEN) Bundle
¡Explore las perspectivas financieras de Penumbra, Inc. (PEN) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones para el crecimiento, los márgenes y los gastos para determinar el valor intrínseco de Penumbra, Inc. (PEN) y mejorar su estrategia de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 560.4 | 747.6 | 847.1 | 1,058.5 | 1,194.6 | 1,447.1 | 1,752.8 | 2,123.2 | 2,571.9 | 3,115.4 |
| Revenue Growth, % | 0 | 33.4 | 13.32 | 24.95 | 12.86 | 21.13 | 21.13 | 21.13 | 21.13 | 21.13 |
| EBITDA | -22.3 | 7.8 | 6.1 | 112.0 | 49.5 | 36.2 | 43.8 | 53.1 | 64.3 | 77.9 |
| EBITDA, % | -3.99 | 1.05 | 0.71795 | 10.58 | 4.15 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| Depreciation | 15.7 | 19.5 | 27.6 | 30.6 | 27.2 | 40.0 | 48.5 | 58.7 | 71.1 | 86.2 |
| Depreciation, % | 2.8 | 2.61 | 3.25 | 2.89 | 2.28 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 |
| EBIT | -38.0 | -11.7 | -21.5 | 81.4 | 22.3 | -3.8 | -4.6 | -5.6 | -6.8 | -8.3 |
| EBIT, % | -6.78 | -1.56 | -2.54 | 7.69 | 1.87 | -0.26498 | -0.26498 | -0.26498 | -0.26498 | -0.26498 |
| Total Cash | 264.8 | 254.9 | 188.0 | 289.2 | 340.1 | 461.1 | 558.6 | 676.6 | 819.6 | 992.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 114.6 | 133.9 | 203.4 | 201.8 | 167.7 | 276.3 | 334.7 | 405.4 | 491.1 | 594.9 |
| Account Receivables, % | 20.45 | 17.92 | 24.01 | 19.06 | 14.04 | 19.09 | 19.09 | 19.09 | 19.09 | 19.09 |
| Inventories | 219.5 | 263.5 | 334.0 | 388.0 | 406.7 | 534.1 | 647.0 | 783.7 | 949.3 | 1,149.9 |
| Inventories, % | 39.17 | 35.25 | 39.43 | 36.66 | 34.05 | 36.91 | 36.91 | 36.91 | 36.91 | 36.91 |
| Accounts Payable | 14.1 | 13.4 | 26.7 | 27.2 | 31.3 | 36.6 | 44.3 | 53.7 | 65.1 | 78.8 |
| Accounts Payable, % | 2.52 | 1.8 | 3.15 | 2.57 | 2.62 | 2.53 | 2.53 | 2.53 | 2.53 | 2.53 |
| Capital Expenditure | -24.8 | -21.2 | -19.3 | -15.2 | -21.2 | -36.9 | -44.7 | -54.1 | -65.5 | -79.4 |
| Capital Expenditure, % | -4.42 | -2.83 | -2.28 | -1.44 | -1.77 | -2.55 | -2.55 | -2.55 | -2.55 | -2.55 |
| Tax Rate, % | 32.86 | 32.86 | 32.86 | 32.86 | 32.86 | 32.86 | 32.86 | 32.86 | 32.86 | 32.86 |
| EBITAT | -19.3 | 2.9 | 11.1 | 92.9 | 15.0 | -1.7 | -2.0 | -2.5 | -3.0 | -3.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -348.4 | -62.8 | -107.4 | 56.4 | 40.6 | -229.2 | -161.7 | -195.9 | -237.3 | -287.4 |
| WACC, % | 6.22 | 6.17 | 6.17 | 6.27 | 6.24 | 6.21 | 6.21 | 6.21 | 6.21 | 6.21 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -921.7 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -299 | |||||||||
| Terminal Value | -13,497 | |||||||||
| Present Terminal Value | -9,984 | |||||||||
| Enterprise Value | -10,906 | |||||||||
| Net Debt | -101 | |||||||||
| Equity Value | -10,805 | |||||||||
| Diluted Shares Outstanding, MM | 39 | |||||||||
| Equity Value Per Share | -275.16 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real PEN financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Penumbra’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for Penumbra, Inc. (PEN).
- Adjustable Forecast Inputs: Modify highlighted fields such as WACC, growth rates, and profit margins to tailor your analysis.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Utilize user-friendly charts and summaries to effectively visualize your valuation findings.
- Designed for All Skill Levels: A straightforward, intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Download: Get the pre-built Excel file featuring Penumbra, Inc.'s (PEN) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: Watch intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and analyze results instantly.
- Make Decisions: Leverage the valuation insights to inform your investment approach.
Why Choose This Calculator for Penumbra, Inc. (PEN)?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for Penumbra, Inc. (PEN).
- Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Penumbra’s intrinsic value and Net Present Value.
- Preloaded Information: Access historical and forecasted data for precise calculations.
- High-Quality Standards: Perfect for financial analysts, investors, and business advisors focused on Penumbra, Inc. (PEN).
Who Should Use Penumbra, Inc. (PEN)?
- Healthcare Investors: Make informed investment choices with a comprehensive analysis of Penumbra's market potential.
- Medical Device Analysts: Streamline your evaluations with a detailed financial model tailored for Penumbra's offerings.
- Consultants in Healthcare: Effortlessly customize presentations or reports focused on Penumbra's innovative solutions.
- Medical Technology Enthusiasts: Enhance your knowledge of the industry by exploring Penumbra's advancements and strategies.
- Educators and Students in Healthcare Finance: Utilize it as a hands-on resource for learning about the financial aspects of medical technology.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Penumbra historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Penumbra, Inc. (PEN).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.